The effect of sumatriptan on brain monoamines in rats

Headache

Volumn 36, Issue 1, 1996, Pages 29-31

  Mitsikostas, D D ^a,b   Papadopoulou Daifotis, Z ^a   Sfikakis, A ^a   Varonos, D ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b ATHENS NAVAL HOSPITAL   (Greece)

Author keywords

dopamine; hypothalamus; serotonin; striatum; sumatriptan

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; ANTIMIGRAINE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHLORPROMAZINE; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; FLUNARIZINE; HALOPERIDOL; MONOAMINE; PROPRANOLOL; SEROTONIN; SEROTONIN 1 RECEPTOR; SULPIRIDE; SUMATRIPTAN SUCCINATE; VALPROIC ACID;

5 HYDROXYINDOLEACETIC ACID BRAIN LEVEL; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN METABOLISM; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DRUG BLOOD LEVEL; DRUG EFFECT; FRONTAL CORTEX; HEADACHE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; HYPOTHALAMUS; MALE; MIGRAINE; NEUROPHARMACOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL; SUBCUTANEOUS DRUG ADMINISTRATION;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BIOGENIC MONOAMINES; BRAIN; DOPAMINE; HOMOVANILLIC ACID; HYDROXYINDOLEACETIC ACID; MALE; RATS; RATS, WISTAR; SEROTONIN; SEROTONIN AGONISTS; SUMATRIPTAN;

EID: 0030039037     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.1996.3601029.x     Document Type: Article

References (21)

1. Humphrey PP, FeniukW, Marriot AS,Tanner RJ, Jackson MR, Tucker ML. Preclinical studies on the anti-migraine drug, sumatriptan. Eur Neural. 1991;31:282-290.
2. The Multinational Oral Sumatriptan and Cafergot Comparative Study Group. A randomized, double-blind comparison of sumatriptan and Cafergot in the acute treatment of migraine. Eur Neural. 1991;31:314-322.
3. Nappi G, Sicuteri F, Byrne M, Roncolato M, Zerbini O. Oral sumatriptan compared with placebo in the acute treatment of migraine. J Neurol. 1994:241:138-144.
4. Russell MB, Holm-Thomsen OE, Rishoj Nielsen M, Cleal A, Pilgrim AJ, Olesen J. A randomized double-blind placebo-controlled crossover study of subcutaneous sumatriptan in general practice. Cephalalgia. 1994;14:291-296.
5. Tfelt-Hansen P, Lipton RB. Migraine: prioritizing acute pharmacotherapy. In: Olesen J, Tfelt-Hansen P, Welch KMA, eds. The Headaches. New York: Raven Press; 1993:359-361.
6. Ferrari MD. Sumatriptan in the treatment of migraine. Neurology. 1993;43(suppl 3):S43-S47.
7. Welch KMA. Drug therapy of migraine. N Engl J Med. 1993;329:1476-1483.
8. Butler A, Worton S, Connor HE. Sumatriptan does not attenuate sensory nerve-mediated relaxations of guineapig isolated pulmonary artery. Br J Pharmacol. 1992;105:273.
9. Waldron GJ, O'Shaughnessy CT, Connor HE. Sumatriptan does not modify capsaicin-induced relaxation of guinea-pig isolated basilar artery. Br J Pharmacol. 1992;105:272.
10. O'Shaughnessy CT, Connor HE, Feniuk W. Extracellular recordings of membrane potential from guinea-pig isolated trigeminal ganglion: lack of effect of sumatriptan. Cephalalgia. 1993; 13:175-179.
11. Saxena PR, Tfelt-Hansen P. Migraine: sumatriptan. In: Olesen J, Tfelt-Hansen P, Welch KMA, eds. The Headaches. New York: Raven Press; 1993:329-341.
12. Welch KMA, Barkley GL,Tepley N, Ramadan NM. Central neurogenic mechanisms of migraine. Neurology. 1993;43(suppl 3):S21-S25.
13. Lance JW. Current concepts of migraine pathogenesis. Neurology, 1993;43 (suppl 3):S11-S15.
14. Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain. 1994;117:199-210.
15. Anthony M. The biochemistry of migraine. In: Rose FC, ed. The Handbook of Clinical Neurology. IV. New York: Elsevier Science Publishing Co, Inc; 1986:85-105.
16. Sharp T, Zetterstrom T, Series HG, Carlsson A, GrahameSmith DG, Ungerstedt U. HPLC-EC analysis of cathechols agnd indoles in rat brain dialysates. Life Sci. 1987;41:869-872.
17. Fowler PA, Lacey LF, Thomas M, Keene ON, Tanner RJ, Saber NS. The clinical pharmacology, pharmacokinetics and metabolism of sumatriptan. Eur Neurol. 1991;31:291-294.
18. Mitsikostas D, Sfikakis A, Papadopoulou-Diafoti Z, Varonos D. The effects of valproate in brain monoamines of juvenile rats after stress. Prog Neuropsychopharmacol Biol Psychiatry. 1993;17:295-310.
19. Mitsikostas DD. The valproate mechanisms of action in migraine (letter). Cephalalgia. 1994;14:465.
20. Fadda F, Gessa GL, Mosca E, Stefanini E. Different effects of the calcium antagonists nimodipine and flunarizine on dopamine metabolism in the rat brain. J Neural Transm. 1989;75:195-200.
21. Pani L, Kuzmin A, Stefanini E, Gessa GL, Rossetti ZL. Flunarizine potentiates cocaine-induced dopamine release and motor stimulation in rats. Eur J Pharmacol. 1990;190:223-227.